Related Experiment Video
Updated: Oct 3, 2025
Author Spotlight: Nuclei Isolation from Mouse Cardiac Progenitor Cells for Epigenome and Gene Expression Profiling at Single-Cell Resolution
Published on: May 12, 2023
Applications of Single-Cell RNA Sequencing in Cardiovascular Research
Yu Fan1,2, Han Zhou1, Xuexue Liu1
1Key Laboratory of Medical Electrophysiology, Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Collaborative Innovation Center for Prevention of Cardiovascular Diseases, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China.
Insights
Single-cell RNA sequencing (scRNA-seq) offers new insights into cardiovascular disease (CVD) development and treatment. This technology reveals cellular details crucial for understanding and combating heart disease.
Area of Science:
- Cardiovascular Biology
- Genomics
- Translational Medicine
Background:
- Cardiovascular disease (CVD) remains a primary global health concern.
- Advancements in sequencing technologies, particularly single-cell RNA sequencing (scRNA-seq), are revolutionizing biological research.
- scRNA-seq enables high-resolution analysis of cellular heterogeneity and interactions.
Purpose of the Study:
- To review recent findings on cardiovascular system development and disease pathogenesis using scRNA-seq.
- To explore the application of scRNA-seq in identifying novel therapeutic targets for CVD.
- To discuss future directions for scRNA-seq in cardiovascular research.
Main Methods:
- Review of current literature on scRNA-seq applications in cardiovascular research.
- Analysis of studies detailing cardiovascular embryogenesis and disease mechanisms at the single-cell level.
- Synthesis of findings related to cell fate, heterogeneity, and interactions.
Main Results:
- scRNA-seq has elucidated key aspects of cardiovascular embryological development.
- The technology has provided novel insights into the pathogenesis of various cardiovascular diseases.
- Potential therapeutic targets for CVD have been identified through scRNA-seq analysis.
Conclusions:
- scRNA-seq is a powerful tool for understanding cardiovascular biology and disease.
- This technology holds significant promise for the development of targeted CVD treatments.
- Future research should leverage scRNA-seq to further advance cardiovascular medicine.
Abstract:
In recent years, cardiovascular disease (CVD) continues to be the leading cause of global disease burden. Extensive efforts have been made across basic, translational, and clinical research domains to curb the CVD epidemic and improve the health of the population. The successful completion of the Human Genome Project catapulted sequencing technology into the mainstream and aroused the interests of clinicians and scientific researchers alike. Advances in single-cell RNA sequencing (scRNA-seq), which is based on the transcriptional phenotypes of individual cells, have enabled the investigation of cellular fate, heterogeneity, and cell-cell interactions, as well as cell lineage determination, at a single-cell resolution. In this review, we summarize recent findings on the embryological development of the cardiovascular system and the pathogenesis and treatment of cardiovascular disease, as revealed by scRNA-seq technology. In particular, we discuss how scRNA-seq can help identify potential targets for the treatment of cardiovascular diseases and conclude with future perspectives for scRNA-seq.
